期刊文献+

从系统论看肿瘤的生物靶向性治疗 被引量:5

Discussion on Biological Target Therapy of Tumor from Point View of System Theory
下载PDF
导出
摘要 肿瘤的生物靶向性治疗是恶性肿瘤治疗的新方法,其试图通过在基因水平上调节与肿瘤发生、发展有密切联系的生命物质来达到治愈肿瘤的目的。但临床运用中,生物靶向性治疗的疗效与我们的想象相去甚远。本文运用系统论的观点,分析目前生物靶向性治疗中存在的问题及寻求可能解决的方法。 Bioiogicai target therapy is a novei treatment of cancer, which tempts to reguiate the materiais associated closely with the occurrence and development of tumor through modulation of gene expression. However, in the clinical application' there is a far distance between its efficacy and our expectation. In this article, we used the system theory to analyze the existing problems in the present biological target therapy, and seek the possible approaches to tackle them.
出处 《医学与哲学(B)》 2008年第1期66-67,共2页 Medicine & Philosophy(B)
关键词 系统论 肿瘤 生物靶向性治疗 system theory, tumor, biological target therapy
  • 相关文献

参考文献5

二级参考文献18

  • 1Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancers [J]. Science, 1994, 266:2011 - 2015.
  • 2Doyle LA, Highsmith WE. Telomerase as a diagnostic and therapeutic target for cancer [J]. Expert Rev Anticancer Ther,2002, 2:217 - 225.
  • 3Komata T, Kanzawa T, Kondo Y. et al.Telomerase as a therapeutic target for malignant gliomas [J]. Oncogene, 2002,21 : 656 - 663.
  • 4Vonderheide RH, Hahn WC, Schuhze JL,et al. The telomerase catalytic subunit is widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes [J]. Immunity, 1999, 10:673 - 679.
  • 5Vonderheide RH. Telomerase as a universal tumor-associated antigen for cancer immunotherapy [J] . Oncogene,2002, 21:674 - 679.
  • 6Ducrest AL, Szutorisz H, Lingner J, et al.Regulation of the human telomerase reverse transcriptase gene [J ]. Oncogene,2002, 21:541 -552.
  • 7Harley CB. Telomerase is not an oncogene [J]. Oncogene, 2002, 21:494 - 502.
  • 8Arai J, Yasukawa M, Ohminami H, et al.Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-24-restricted antileukemia cytotoxic T lymphocytes [J]. Blood, 2001, 97:2903 - 2907.
  • 9Scardino A, Gross DA, Alves P, et al.HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immmnotherapy [J]. J Immunol, 2002,168:5900 - 5906.
  • 10Vonderheide RH, Anderson KS, Hahn WC, et al. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase [J]. Clin Cancer Res,2001, 7:3343 - 3348.

共引文献18

同被引文献51

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部